The Extraordinary Hope of Antiretroviral Therapy in South Africa (Even for Patients with Tuberculosis or Kaposi Sarcoma!)

Flanigan, Timothy P.; Campbell, Thomas; Harwell, Joseph; Kumarasamy, N.
February 2005
Journal of Infectious Diseases;2/1/2005, Vol. 191 Issue 3, p321
Academic Journal
The article discusses the importance of antiretroviral therapy (ART) in the HIV and Aids treatment in South Africa. HIV and AIDS treatment in North America and Europe was revolutionized by the use of triple combination ART, which resulted in dramatic decreases in morbidity and mortality. morbidity and mortality. As the potency, adverse effects, and ease of ART administration continue to improve, HIV is becoming more and more manageable within the developed world. The hallmark of triple combination ART has been profound suppression of viral load to undetectable levels with increases in CD4 cell counts. Moreover, ART has uniformly translated to improved health for HIV-infected persons by decreasing the risk of AIDS-related complications and death, as well as by decreasing the overall cost of medical care.


Related Articles

  • The cost of antiretroviral treatment service for patients with HIV/AIDS in a central outpatient clinic in Vietnam. Long Thanh Nguyen; Bach Xuan Tran; Cuong Tuan Tran; Huong Thi Le; Son Van Tran // ClinicoEconomics & Outcomes Research;2014, Vol. 6, p101 

    Introduction: Antiretroviral treatment (ART) services are estimated to account for 30% of the total resources needed for human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS) control and prevention in Vietnam during the 2011-2020 timeframe. With international funding...

  • Free antiretroviral treatment effective in Malawi.  // Infectious Disease News;Jun2008, Vol. 21 Issue 6, p39 

    The article reports on the results of a study on the efficiency of antiretroviral therapy in Malawi. It revealed that mortality rates of patients with HIV and AIDS have been reduced following the introduction of free antiretroviral therapy. According to researchers, the mortality rate was 9.8...

  • Combination therapy for HIV: the effect on inpatient activity, morbidity and mortality of a cohort of patients. Brettle, Ray P.; Wilson, Alan; Povey, Sarah; Morris, Sheila; Morgan, Rhoda; Leen, Clifford L. S.; Hutchinson, Sharon; Lewis, Steff; Gore, Sheila; Brettle, R P; Wilson, A; Povey, S; Morris, S; Morgan, R; Leen, C L; Hutchinson, S; Lewis, S; Gore, S // International Journal of STD & AIDS;Feb1998, Vol. 9 Issue 2, p80 

    We set out to quantify the changes in HIV-related morbidity and mortality associated with the clinical use of antiretroviral therapy via prospectively collected patient-related events (admissions, bed days, deaths, WHO stage 3 and 4 events and drug costs) on all HIV patients known to the...

  • High Risk of ART Non-Adherence and Delay of ART Initiation among HIV Positive Double Orphans in Kigali, Rwanda. Kikuchi, Kimiyo; Poudel, Krishna C.; Muganda, John; Majyambere, Adolphe; Otsuka, Keiko; Sato, Tomoko; Mutabazi, Vincent; Nyonsenga, Simon Pierre; Muhayimpundu, Ribakare; Jimba, Masamine; Yasuoka, Junko // PLoS ONE;Jul2012, Vol. 7 Issue 7, p1 

    Background: To reduce HIV/AIDS related mortality of children, adherence to antiretroviral treatment (ART) is critical in the treatment of HIV positive children. However, little is known about the association between ART adherence and different orphan status. The aims of this study were to assess...

  • Voucher Incentives Improve Linkage to and Retention in Care Among HIV-Infected Drug Users in Chennai, India. Solomon, Sunil Suhas; Srikrishnan, Aylur K.; Vasudevan, Canjeevaram K.; Anand, Santhanam; Kumar, Muniratnam Suresh; Balakrishnan, Pachamuthu; Mehta, Shruti H.; Solomon, Suniti; Lucas, Gregory M. // Clinical Infectious Diseases;Aug2014, Vol. 59 Issue 4, p589 

    Modest voucher incentives were associated with significantly better linkage to and retention in care but not with virologic suppression among human immunodeficiency virus (HIV)-infected drug users in Chennai, India, a population with high HIV disease burden and low access to antiretroviral...

  • Effect of Highly Active Antiretroviral Therapy on Hospitalization Characteristics of HIV-Infected Patients. Nuesch, R.; Geigy, N.; Schaedler, E.; Battegay, M. // European Journal of Clinical Microbiology & Infectious Diseases;Sep2002, Vol. 21 Issue 9, p684 

    In order to determine the impact that highly active antiretroviral therapy (HAART) has on inpatients with HIV infection, HIV-infected patients hospitalized from 1994 to1999 at the Department of Internal Medicine, University of Basel, Switzerland, were investigated. During the observation period,...

  • Mortality of HIV-Infected Patients Starting Antiretroviral Therapy in Sub-Saharan Africa: Comparison with HIVUnrelated Mortality. Brinkhof, Martin W. G.; Boulle, Andrew; Weigel, Ralf; Messou, Eugène; Mathers, Colin; Orrell, Catherine; Dabis, François; Pascoe, Margaret; Egger, Matthias // PLoS Medicine;Apr2009, Vol. 6 Issue 4, p1 

    Background: Mortality in HIV-infected patients who have access to highly active antiretroviral therapy (ART) has declined in sub-Saharan Africa, but it is unclear how mortality compares to the non-HIV-infected population. We compared mortality rates observed in HIV-1-infected patients starting...

  • Early ART a good start in opportunistic infections.  // PharmacoEconomics & Outcomes News;8/22/2009, Issue 585, p5 

    The article reports on a study in the U.S. which investigated the cost effectiveness and impact of early initiation of antiretroviral therapy (ART) in patients with HIV. The estimated cost reported for early ART initiation is 1650 U.S. dollars per patient. Compared to deferred ART, researchers...

  • Cost of noninfectious comorbiditiesin patients with HIV. Guaraldi, Giovanni; Zona, Stefano; Menozzi, Marianna; Carli, Federica; Bagni, Pietro; Berti, Alessandra; Rossi, Elisa; Orlando, Gabriella; Zoboli, Giuliana; Palella, Frank // ClinicoEconomics & Outcomes Research;2013, Vol. 5, p481 

    Objectives: We hypothesized that the increased prevalence of noninfectious comorbidities (NICMs) observed among HIV-infected patients may result in increased direct costs of medical care compared to the general population. Our objective was to provide estimates of and describe factors...


Read the Article

Courtesy of

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics